BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 25832698)

  • 1. Lung cancer cell line screen links fanconi anemia/BRCA pathway defects to increased relative biological effectiveness of proton radiation.
    Liu Q; Ghosh P; Magpayo N; Testa M; Tang S; Gheorghiu L; Biggs P; Paganetti H; Efstathiou JA; Lu HM; Held KD; Willers H
    Int J Radiat Oncol Biol Phys; 2015 Apr; 91(5):1081-9. PubMed ID: 25832698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disruption of SLX4-MUS81 Function Increases the Relative Biological Effectiveness of Proton Radiation.
    Liu Q; Underwood TSA; Kung J; Wang M; Lu HM; Paganetti H; Held KD; Hong TS; Efstathiou JA; Willers H
    Int J Radiat Oncol Biol Phys; 2016 May; 95(1):78-85. PubMed ID: 27084631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Difference in the relative biological effectiveness and DNA damage repair processes in response to proton beam therapy according to the positions of the spread out Bragg peak.
    Hojo H; Dohmae T; Hotta K; Kohno R; Motegi A; Yagishita A; Makinoshima H; Tsuchihara K; Akimoto T
    Radiat Oncol; 2017 Jul; 12(1):111. PubMed ID: 28673358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relative biological effectiveness of high linear energy transfer α-particles for the induction of DNA-double-strand breaks, chromosome aberrations and reproductive cell death in SW-1573 lung tumour cells.
    Franken NA; Hovingh S; Ten Cate R; Krawczyk P; Stap J; Hoebe R; Aten J; Barendsen GW
    Oncol Rep; 2012 Mar; 27(3):769-74. PubMed ID: 22200791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variations in the RBE for cell killing along the depth-dose profile of a modulated proton therapy beam.
    Britten RA; Nazaryan V; Davis LK; Klein SB; Nichiporov D; Mendonca MS; Wolanski M; Nie X; George J; Keppel C
    Radiat Res; 2013 Jan; 179(1):21-8. PubMed ID: 23148508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiobiological characterization of two therapeutic proton beams with different initial energy spectra used at the Institut Curie Proton Therapy Center in Orsay.
    Calugaru V; Nauraye C; Noël G; Giocanti N; Favaudon V; Mégnin-Chanet F
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):1136-43. PubMed ID: 21075549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relative biological effectiveness variation along monoenergetic and modulated Bragg peaks of a 62-MeV therapeutic proton beam: a preclinical assessment.
    Chaudhary P; Marshall TI; Perozziello FM; Manti L; Currell FJ; Hanton F; McMahon SJ; Kavanagh JN; Cirrone GA; Romano F; Prise KM; Schettino G
    Int J Radiat Oncol Biol Phys; 2014 Sep; 90(1):27-35. PubMed ID: 24986743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of the Fanconi anemia/BRCA pathway and recombination repair in the cellular response to solar ultraviolet light.
    Dunn J; Potter M; Rees A; Rünger TM
    Cancer Res; 2006 Dec; 66(23):11140-7. PubMed ID: 17145857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A mechanism-based approach to predict the relative biological effectiveness of protons and carbon ions in radiation therapy.
    Frese MC; Yu VK; Stewart RD; Carlson DJ
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):442-50. PubMed ID: 22099045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of impaired homologous recombination repair in NSCLC cells and tissues.
    Birkelbach M; Ferraiolo N; Gheorghiu L; Pfäffle HN; Daly B; Ebright MI; Spencer C; O'Hara C; Whetstine JR; Benes CH; Sequist LV; Zou L; Dahm-Daphi J; Kachnic LA; Willers H
    J Thorac Oncol; 2013 Mar; 8(3):279-86. PubMed ID: 23399959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arsenic exposure disrupts the normal function of the FA/BRCA repair pathway.
    Peremartí J; Ramos F; Marcos R; Hernández A
    Toxicol Sci; 2014 Nov; 142(1):93-104. PubMed ID: 25092648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Most DNA repair defects do not modify the relationship between relative biological effectiveness and linear energy transfer in CRISPR-edited cells.
    Guerra Liberal FDC; Parsons JL; McMahon SJ
    Med Phys; 2024 Jan; 51(1):591-600. PubMed ID: 37753877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring the link between MORF4L1 and risk of breast cancer.
    Martrat G; Maxwell CM; Tominaga E; Porta-de-la-Riva M; Bonifaci N; Gómez-Baldó L; Bogliolo M; Lázaro C; Blanco I; Brunet J; Aguilar H; Fernández-Rodríguez J; Seal S; Renwick A; Rahman N; Kühl J; Neveling K; Schindler D; Ramírez MJ; Castellà M; Hernández G; ; Easton DF; Peock S; Cook M; Oliver CT; Frost D; Platte R; Evans DG; Lalloo F; Eeles R; Izatt L; Chu C; Davidson R; Ong KR; Cook J; Douglas F; Hodgson S; Brewer C; Morrison PJ; Porteous M; Peterlongo P; Manoukian S; Peissel B; Zaffaroni D; Roversi G; Barile M; Viel A; Pasini B; Ottini L; Putignano AL; Savarese A; Bernard L; Radice P; Healey S; Spurdle A; Chen X; Beesley J; ; Rookus MA; Verhoef S; Tilanus-Linthorst MA; Vreeswijk MP; Asperen CJ; Bodmer D; Ausems MG; van Os TA; Blok MJ; Meijers-Heijboer HE; Hogervorst FB; ; Goldgar DE; Buys S; John EM; Miron A; Southey M; Daly MB; ; ; Harbst K; Borg A; Rantala J; Barbany-Bustinza G; Ehrencrona H; Stenmark-Askmalm M; Kaufman B; Laitman Y; Milgrom R; Friedman E; Domchek SM; Nathanson KL; Rebbeck TR; Johannsson OT; Couch FJ; Wang X; Fredericksen Z; Cuadras D; Moreno V; Pientka FK; Depping R; Caldés T; Osorio A; Benítez J; Bueren J; Heikkinen T; Nevanlinna H; Hamann U; Torres D; Caligo MA; Godwin AK; Imyanitov EN; Janavicius R; ; Sinilnikova OM; Stoppa-Lyonnet D; Mazoyer S; Verny-Pierre C; Castera L; de Pauw A; Bignon YJ; Uhrhammer N; Peyrat JP; Vennin P; Ferrer SF; Collonge-Rame MA; Mortemousque I; McGuffog L; Chenevix-Trench G; Pereira-Smith OM; Antoniou AC; Cerón J; Tominaga K; Surrallés J; Pujana MA
    Breast Cancer Res; 2011 Apr; 13(2):R40. PubMed ID: 21466675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relative biological effectiveness (RBE) values for proton beam therapy.
    Paganetti H; Niemierko A; Ancukiewicz M; Gerweck LE; Goitein M; Loeffler JS; Suit HD
    Int J Radiat Oncol Biol Phys; 2002 Jun; 53(2):407-21. PubMed ID: 12023146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exponential Increase in Relative Biological Effectiveness Along Distal Edge of a Proton Bragg Peak as Measured by Deoxyribonucleic Acid Double-Strand Breaks.
    Cuaron JJ; Chang C; Lovelock M; Higginson DS; Mah D; Cahlon O; Powell S
    Int J Radiat Oncol Biol Phys; 2016 May; 95(1):62-69. PubMed ID: 27084629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance and implementation of RBE variations in proton beam therapy.
    Paganetti H
    Technol Cancer Res Treat; 2003 Oct; 2(5):413-26. PubMed ID: 14529306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiation response in vitro of fibroblasts from a fanconi anemia patient with marked clinical radiosensitivity.
    Djuzenova C; Flentje M; Plowman PN
    Strahlenther Onkol; 2004 Dec; 180(12):789-97. PubMed ID: 15592699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spot Scanning and Passive Scattering Proton Therapy: Relative Biological Effectiveness and Oxygen Enhancement Ratio in Cultured Cells.
    Iwata H; Ogino H; Hashimoto S; Yamada M; Shibata H; Yasui K; Toshito T; Omachi C; Tatekawa K; Manabe Y; Mizoe JE; Shibamoto Y
    Int J Radiat Oncol Biol Phys; 2016 May; 95(1):95-102. PubMed ID: 27084632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclin D1 is Associated with Radiosensitivity of Triple-Negative Breast Cancer Cells to Proton Beam Irradiation.
    Choi C; Park S; Cho WK; Choi DH
    Int J Mol Sci; 2019 Oct; 20(19):. PubMed ID: 31591311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction between the biological effects of high- and low-LET radiation dose components in a mixed field exposure.
    Mason AJ; Giusti V; Green S; Munck af Rosenschöld P; Beynon TD; Hopewell JW
    Int J Radiat Biol; 2011 Dec; 87(12):1162-72. PubMed ID: 21923301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.